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The function of inspiratory muscles is crucial for effective
cough as well as expiratory muscles in patients with Duchenne
muscular dystrophy (DMD). However, there is no report on
the correlation between cough and inspiratory muscle strength.
To investigate the relationships of voluntary cough capacity,
assisted cough techniques, and inspiratory muscle strength as
well as expiratory muscle strength in patients with DMD (n=
32). The vital capacity (VC), maximum insufflation capacity
(MIC), maximal inspiratory pressure (MIP), and maximal ex-
piratory pressure (MEP) were measured. Unassisted peak
cough flow (UPCF) and three different techniques of assisted
PCF were evaluated. The mean value of MICs (1918 ± 586
mL) was higher than that of VCs (1474 ± 632 mL) (p <
0.001). All three assisted cough methods showed significantly
higher value than unassisted method (212 ± 52 L/min) (F =
66.13, p < 0.001). Combined assisted cough technique (both
manual and volume assisted PCF; 286 ± 41 L/min) signifi-
cantly exceeded manual assisted PCF (MPCF; 246 ± 49 L/
min) and volume assisted PCF (VPCF; 252 ± 45 L/min) (F =
66.13, p < 0.001). MIP (34 ± 13 cmH2O) correlated signifi-
cantly with both UPCF and all three assisted PCFs as well as
MEP (27 ± 10 cmH2O) (p < 0.001). Both MEP and MIP,
which are the markers of respiratory muscle weakness, should
be taken into account in the study of cough effectiveness.
Key Words: Duchenne muscular dystrophy, cough, assisted
cough, peak cough flow, maximal inspiratory pressure, maxi-
mal expiratory pressure
INTRODUCTION
Duchenne muscular dystrophy (DMD) causes
progressive weakness of respiratory muscles, in
common with other skeletal muscles, over the
course of the disease.
1 Vital capacity increases
concomitantly with the physical growth until the
early teens, however, it begins to decrease earlier
in the DMD patients than the normal persons
followed by plateau.
2 As growth slows and mus-
cle weakness progresses, the vital capacity enters
a descending phase and declines at an average
rate of 8-8.5% per year after 10-12 years of age.
3
As a result, patients develop chronic alveolar
hypoventilation in advanced stage.
4
The weakened respiratory muscles can neither
fully expand the lungs up to the maximal capacity
nor compress them to the point of the smallest
residual volume, leading to reduction of chest
wall compliance through shortening and stif-
fening of the unstretched tissue and fibrosis of
dystrophic muscles.
5 The compliance of the lungs
are also reduced by the spreading of microatelec-
tasis in the lungs.
6 This respiratory disability di-
minishes the lung capacity and causes impairment
of the ability to cough.
7 When the force of cough
is diminished, airway secretion can not be suf-
ficiently eliminated. Impaired secretion clearance
results in the development of mucus plugging,
leading to such complications as atelectasis or
pneumonia. In fact, about 90% of respiratory fail-
ures develop suddenly as a result of impaired
clearance of the airways during intercurrent chest
colds due to the ineffective cough.
8 Therefore, the
most important aspect of the pulmonary hygiene
therapy for these patients is to improve the effec-
tiveness of coughing.
For an effective cough, subjects initially inspire
a large amount of air and apply expiratory force
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against a closed glottis, generating high thoraco-
abdominal pressures. At this point, the glottis
opens, resulting in strong expiratory flow.
9,10
Based on this cough mechanism, several cough
assisting methods have been proposed for patients
with respiratory muscle weakness, such as respi-
ratory muscle training,
11 functional electrical stim-
ulation of abdominal muscles,
12 and manual as-
sist coughing following a maximum insufflation.
13
As known in cough mechanism and assisted
coughing techniques, the expiratory muscles play
the most basic and important role in producing a
functional cough flow. Therefore, a great deal of
interests and researches focused on correlation
between expiratory muscle strength and cough.
Although expiratory muscle function is a crucial
part of an effective cough, the lung volume at-
tained prior to contraction of the expiratory mus-
cle also plays an important part during cough.
The function of inspiratory muscles is essential in
inspiratory phase of cough, however, there is no
report on the correlation between cough and
inspiratory muscle strength.
In this study, therefore, we investigated the
relationships of voluntary cough capacity, assisted
cough techniques, and inspiratory muscle strength
as well as expiratory muscle strength.
MATERIALS AND METHODS
Patients
The study subjects were the patients who un-
derwent general examinations such as medical
history, physical findings, muscle enzyme study
and electrodiagnostic study, and were finally
diagnosed as DMD through muscle biopsy or
DNA analysis. The study included 32 patients
who were selected from the patients in the grade
5 or over of the functional level classification
proposed by Swinyard et al.
14 The study ex-
cluded those patients who had concomitant
intrinsic lung disease or indwelling tracheostomy
tube, and who were unable to cooperate because
of mental or physical problem. The protocol of
the study was approved by the Hospital Ethical
Committee.
Methods
Vital capacity (VC) and maximum insufflation
capacity (MIC) of the patients were measured in
a sitting position using Wright spirometer (Ferraris
Development & Engineering Co Ltd, Northants,
UK). For measuring MIC, the patient was told to
take a deep breath and then hold it. A volume of
air is then delivered via a mouth piece or oronasal
interface by using a manual resuscitator bag. The
patient adds this air to what was already in the
lungs and holds it with the glottis closed. The
process was repeated until no more air could be
held, and the lungs and chest wall were fully
expanded. The maximally stacked volume of air
was measured by having the patient blow the
entire volume through the spirometer. This pro-
cess was repeated at least three times and the
highest value was selected as the MIC.
The maximal respiratory pressure reflecting the
strength of respiratory muscles were measured by
mouth pressure meter (Spirovis, Cosmed Srl,
Rome, Italy) in a sitting position. To measure a
maximal expiratory pressure (MEP), the subject
performed a maximal expiratory effort after a
maximal inspiration. Maximal inspiratory pres-
sure (MIP) was measured by exerting a maximal
inspiratory effort after a maximal expiration. The
pressures measured should be maintained for at
least one second. The highest positive value for
MEP and the lowest negative value for MIP in
three or more attempts were chosen. The absolute
value of MIP was used for analyzing the data.
The peak cough flows (PCFs) were measured
using a peak flow meter (Health Scan Products
Inc, Cedar Grove, NJ, USA). Unassisted peak
cough flow (UPCF) was measured by having the
person cough as forcefully as possible through the
peak flow meter. Three different techniques of
assisted PCF were evaluated. To measure volume
assisted peak cough flow (VPCF) which assists
inspiratory phase of cough, patients were insuf-
flated to the MIC and then coughed as forcefully
as possible. Manual assisted peak cough flow
(MPCF), which assists expiratory muscle function,
was measured while abdominal thrust was timed
to glottic opening. Both techniques were carried
out simultaneously in the combined assisted cough
technique as combined peak cough flow (CPCF).Seong-Woong Kang, et al.
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It consisted of manual abdominal compression
during the expulsive phase of a maximal volun-
tary cough after insufflating to MIC. We com-
pared the PCFs under four different conditions.
The highest value in at least three trials was used
in each tests, and the correlation between the MIP,
MEP and PCFs under each condition was
evaluated.
Statistical analysis
A paired t test was used for the comparison
between VC and MIC, and repeated measure
analysis of variance was used for the comparisons
between UPCF and each assisted PCF. If repeated
measure analysis of variance detect significance, a
post hoc comparison test was performed by least
significant difference (LSD). A relationship between
the maximal respiratory pressures and the PCFs
was analyzed through a coefficients of correlation.
All data were analyzed by using SPSS 11.0 for
Windows (SPSS Inc, Chicago, IL, USA).
RESULTS
Thirty-two male DMD patients were involved.
Mean age was 17.6 ± 5.1 years old, mean height
was 153.3 ± 8.8 cm, and mean weight was 44.9 ±
13.2 kg. The average values of VCs and MICs
were 1474 ± 632 mL(45.2 ± 22.5% of predicted
normal value
15,16) and 1918 ± 586 mL, respec-
tively, and the mean values of MIPs and MEPs
were 34 ± 13 cmH2O (41.7 ± 16.9% of predicted
normal value
17) and 27 ± 10 cmH2O (21.6 ± 10.8%
of predicted normal value
17), respectively. The
mean PCFs under different conditions were:
UPCF, 212 ± 52 L/min; VPCF, 252 ± 45 L/min;
MPCF, 246 ± 49 L/min; CPCF, 286 ± 41 L/min.
The mean value of MICs was higher than that
of VCs (p < 0.001). All of three assisted cough
methods showed significantly higher value than
Table 1. Comparisons between UPCF* and Each Assisted PCF (n = 32)
UPCF VPCF MPCF
§ CPCF F value
212 ± 52 252 ± 45 246 ± 49 286 ± 41 66.13
¶,
Mean values ± SD (liters/min).
*UPCF = unassisted peak cough flow; PCF = peak cough flow; VPCF = volume assisted peak cough flow;
§MPCF = manual assisted
peak cough flow; CPCF = combined peak cough flow,
¶p < 0.001, **Both the values of VPCF and MPCF, which were similar, were
higher than that of UPCF but lower than that of CPCF.
Fig. 1. Relationships between maximal
respiratory pressures and UPCF. Both ab-
solute value of MIP and MEP correlated
significantly with UPCF. UPCF, Unas-
sisted peak cough flow; MIP, Maximal
inspiratory pressure; MEP, Maximal ex-
piratory pressure.
**Respiratory Muscle Strength, Cough Capacity
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unassisted method (F = 66.13, p < 0.001), and CPCF
significantly exceeded MPCF and VPCF (F = 66.13,
p < 0.001) (Table 1). MEP correlated with volun-
tary cough capacity (UPCF) as expected (p <
0.001) (Fig. 1). Positive correlations between MEP
and three different assisted cough methods were
also evident (p < 0.001) (Fig. 2, 3, 4). In the rela-
tionship between absolute value of MIP and PCFs,
MIP correlated significantly with both UPCF (Fig.
1) and all of three assisted PCFs (p < 0.001) (Fig.
2, 3, 4).
DISCUSSION
The maximal respiratory pressure is a useful
Fig. 2. Relationships between maximal
respiratory pressures and VPCF. Both ab-
solute value of MIP and MEP correlated
significantly with VPCF. VPCF, Volume
assisted peak cough flow; MIP, Maximal
inspiratory pressure; MEP, Maximal ex-
piratory pressure.
Fig. 3. Relationships between maximal
respiratory pressures and MPCF. Both ab-
solute value of MIP and MEP correlated
significantly with MPCF. MPCF, Manual
assisted peak cough flow; MIP, Maximal
inspiratory pressure; MEP, Maximal ex-
piratory pressure.Seong-Woong Kang, et al.
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marker of respiratory muscle weakness. Gener-
ally, the VC in DMD patients doesn't show an
apparent decrement until 10 years old, and the
maximal respiratory pressure begins to decline
earlier in the course of the disease.
18 It suggests
that maximal respiratory pressure is more sensi-
tive for the detection of weakness of respiratory
muscles than pulmonary volumes.
19 The weakness
of the respiratory muscles induces restrictive lung
disease and causes ineffective cough. Cough is an
essential process to prevent pulmonary compli-
cations, such as pneumonia and atelectasis, by
removing excessive pulmonary secretions from
the airways.
10,20 Weakened respiratory muscles in
these patients cannot effectively expel the pulmo-
nary secretions, particularly when secretions are
increased by respiratory tract infections. The
consequence of impaired secretion clearance is the
development of mucus plugging, leading to such
acute complications as atelectasis or pneumonia
due to bronchial plugging.
To be an effective cough, three actions of nor-
mal cough (inspiration, compression, and expul-
sion) should properly be operated.
9 In the inspira-
tion phase, normal subjects increase pre-cough
tidal volumes to about 85 to 90% of their inspira-
tory capacity and have a total cough volume of 2.3
± 0.5 L to obtain optimal PCFs.
20 During the
compression phase, expiratory force against a
closed glottis results in a rapid rise in pleural and
alveolar pressures.
9,10 The contraction of the expi-
ratory muscles with the glottis open strongly
expel the air from the lungs in the expulsion
phase.
9,10 When any of these phases is in an abnor-
mal state, coughing becomes ineffective. If the
sufficient amount of air cannot be voluntarily in-
spired due to the weakness of the inspiratory
muscles, the cough capacity is diminished despite
the normal contraction of the expiratory muscles.
7
A glottis plays a crucial role in the compression
phase, and its function is considerably impaired in
the amyotrophic lateral sclerosis because of in-
volvement of bulbar muscle.
21 However, it doesn't
become an issue in DMD. The expiratory muscle
plays an important role in the compression and
expulsive phases, and its weakness of course re-
duces the effectiveness of cough.
9,10 MEP typically
deteriorates before MIP in patients with DMD.
4
Thus, the declines in MEP correlate well with the
voluntary cough capacity (UPCF), as shown in our
present as well as other studies.
4,10,22
Although the MIP, which reflects the strength
of all inspiratory muscles, is expected to affect the
inspiratory phase of cough, there is no study on
the relation between cough capacity and MIP.
Therefore, we examined the correlation between
the MIP and the cough capacity, and found that
the UPCF had significant correlations with not
Fig. 4. Relationships between maximal
respiratory pressures and CPCF. Both ab-
solute value of MIP and MEP correlated
significantly with CPCF. CPCF, Combined
peak cough flow; MIP, Maximal inspi-
ratory pressure; MEP, Maximal expiratory
pressure.Respiratory Muscle Strength, Cough Capacity
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only MEP, but also MIP. The positive correlations
between maximal respiratory pressures and three
different assisted cough methods were also seen.
As anticipated, the correlation between MIP/MEP
and UPCF was relatively strong. However, the
correlation between MIP/MEP and two assisted
PCFs was lower and the correlation between
MIP/MEP and CPCF was lower still, most likely
because of the extrinsic factors of volume and
manual assisted cough methods becoming more
important in generating peak cough flow. In DMD
patients accompanied with reduced pre-cough
inspiration volume, an assisted coughing method
to assist only the expiratory muscles may not be
sufficient to induce strong cough flow. Therefore,
both manual compression and mechanical insuf-
flation should be considered to assist expectora-
tion of secretions in patients with respiratory
muscle weakness. As seen in the present study,
patients can get the highest cough flow in CPCF
technique. This result together with such relation-
ship between maximal respiratory pressures and
two different assisted cough methods suggest that
both MEP and MIP, which are the markers of
respiratory muscle weakness, should be taken into
account in the study of cough effectiveness.
Deep inspiration expands the more distal air-
ways, improve the expiratory muscle function,
and increases pulmonary recoil pressure of the
respiratory system.
23-25 Forced expiration during
cough normally starts with maximum inflation of
the lungs and greater expiratory pressures, and
flows can be produced at high lung volumes by
optimizing the length-tension relationship of the
expiratory muscles.
24,25 Therefore, cough flow is
reduced by the inspiratory muscle weakness as
well as expiratory muscle weakness.
10,25 As the
strength of inspiratory muscle declines, patients
lose the ability to take spontaneous periodic deep
breaths, which normally stimulate surfactant pro-
duction and distribution, and reopen collapsed
peripheral airways.
26 Without deep insufflations,
these patients first develop microatelectasis, and
long-term inability to take deep breaths or chronic
hypoinflation results in permanent pulmonary
restriction. Thus, decreased pulmonary compli-
ance results initially from microatelectasis, and
ultimately from increased stiffness of the chest
wall and lung tissues themselves.
27 An effective
cough relies on the generation of sufficient dy-
namic airway compression to produce high air-
flow velocities. In contrast, the diminished lung
compliance may limit dynamic airway compres-
sion and can be an another factor to cause weak
coughing.
7 Theses various kinds of factors are
correlated with the MIP and can affect the cough
capacity.
In conclusion, a reduced cough capacity due to
respiratory muscles weakness is one of the main
causes of morbidity and mortality in DMD. It is
generally believed that MIP is correlated with
cough capacity. In reality, the function of inspira-
tory muscle is often overlooked when coughing
methods are used and no study has analyzed the
correlation between MIP and cough flow using
numerical data. We adduced evidence of relation-
ship between MIP and cough flow to emphasize
the importance of inspiratory muscle strength.
The factors to affect a cough should thoroughly be
analyzed to effectively assist weakened cough. As
shown in the present study, not only MEP but
also MIP should be considered in the research of
voluntary or assisted cough capacity.
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